Search

everythinglearnresearchcommunity

for

Search:↓

Autoimmune diseases with high tissue recovery often relapse and remit, while those with low recovery rarely remit.

Alopecia areata is linked to reduced T cell function and auto-immunity.

Machine learning can help identify biomarkers for personalized Pemphigus vulgaris treatment.

Patients with thyroid disorders show different symptoms and antibody levels.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

Monoclonal antibody B72.3 selectively reacts with certain dog tissues, mainly in the gastrointestinal and respiratory tracts.

HKN-2 antibody targets specific skin and hair cells, showing keratin complexity.

Relatives of lupus patients show signs of immune system activity but not full-blown lupus.

Modified superoxide dismutase may trigger an autoimmune response in alopecia areata.

Six months after COVID-19, most patients still had autoantibodies.

A mycobacterial protein shares a similar region with a human skin protein, possibly affecting skin diseases.

Alopecia areata may be caused by antibodies targeting specific hair follicle proteins, hindering hair growth.

Alopecia areata is linked to thyroid autoimmunity but not type 1 diabetes.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

Higher thyroid antibodies in Hashimoto's thyroiditis are linked to more inflammation and symptoms.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

Allergies, especially dust mite allergy, may worsen alopecia areata, and desensitization could help reduce its severity.

Injecting recipient splenocytes into donors' thymus can prevent graft-versus-host disease.

Some hair proteins are specific to hair, while others are also found in skin cells.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Children with frequent severe infections and low antibodies should be checked for immune deficiencies.

The antibody created from BCC tissues reacts similarly to both BCC and hair follicles, suggesting BCC may come from hair follicle cells.

Vaccines are generally safe, but rare autoimmune reactions can occur, often influenced by genetics.

Hair loss treatment caused more hair loss in a man.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.